Rituximab-induced Takotsubo syndrome: More cardiotoxic than it appears?

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Ng, Kien Hoe ^a   Dearden, Claire ^b   Gruber, Pascale ^b  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BISOPROLOL; HYDROCORTISONE; PYRITINOL; RAMIPRIL; RITUXIMAB; TROPONIN; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT;

AGED; ALLERGIC REACTION; ANGIOGRAPHY; AORTA VALVE REGURGITATION; ARTICLE; ATHEROMA; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CORONARY ARTERY DILATATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DYSPNEA; ELECTROCARDIOGRAM; FEVER; FLUSHING; FOLLOW UP; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART VENTRICULOGRAPHY; HUMAN; MALE; MITRAL VALVE REGURGITATION; MUSCLE RIGIDITY; PERICARDIAL EFFUSION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SINUS TACHYCARDIA; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TAKOTSUBO CARDIOMYOPATHY; TRANSTHORACIC ECHOCARDIOGRAPHY; URINE INCONTINENCE; VOMITING; CHEMICALLY INDUCED; ELECTROCARDIOGRAPHY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; ANTINEOPLASTIC AGENTS; BISOPROLOL; ELECTROCARDIOGRAPHY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; RAMIPRIL; RITUXIMAB; TAKOTSUBO CARDIOMYOPATHY; TREATMENT OUTCOME;

EID: 84929121458     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2014-208203     Document Type: Article

References (21)

1. Grunwald MR, Howie L, Diaz LA Jr. Takotsubo syndrome and fluorouracil: Case report and review of the literature. J Clin Oncol 2012; 30: E11-14.
2. Prasad A. Apical ballooning syndrome: An important differential diagnosis of acute myocardial infarction. Circulation 2007; 115: E56-9.
3. Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: A novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol 2001; 38: 11-18.
4. Gianni M, Dentali F, Grandi AM, et al. Apical ballooning syndrome or Takotsubo cardiomyopathy: A systematic review. Eur Heart J 2006; 27: 1523-9.
5. Kurisu S, Sato H, Kawagoe T, et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: A novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002; 143: 448-55.
6. Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy: Diagnosis, pathogenesis, and management. Circulation 2004; 109: 3122-31.
7. Kim L, Karas M, Wong SC. Chemotherapy-induced Takotsubo cardiomyopathy. J Invasive Cardiol 2008; 20: E338-40.
8. Foran JM, Rohaitner AZ, Cunningham D, et al. European Phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle cell lymphoma and previously treated mantle cell lymphoma, immunocytoma, and small B lymphocytic lymphoma. J Clin Oncol 2000; 18: 317-24.
9. Killickap S, Yavuz B, Aksoy S, et al. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma. Med Oncol 2008; 25: 437-42.
10. Cercosimo RJ. Monoclonal antibodies in the treatment of cancer, part 2. Am J Health Syst Pharm 2003; 60: 1631-41.
11. Arunprasath P, Gobu P, Dubashi B, et al. Rituximab induced myocardial infarction: A fatal drug reaction. J Cancer Res Ther 2011; 7: 346-8.
12. Arai Y, Tadokoro J, Mitani K. Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma. Am J Hematol 2005; 78: 317-18.
13. Dillman RO. Infusion reactions associated with the therapeutic use of monoclonal antibodies in the treatment of malignancy. Cancer Metastasis Rev 1999; 18: 465-71.
14. Rituxan official FDA information, side effects and uses. March 2007 (cited 2 Mar 2010). http: Www.drugs.com/pro/rituxan.html
15. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005; 352: 539-48.
16. Kanamori H, Tsutsumi Y, Mori A, et al. Delayed reduction in left ventricular function following treatment of non-Hodgkin's lymphoma with chemotherapy and rituximab, unrelated to acute infusion reaction. Cardiology 2006; 105: 184-7.
17. Martin M, Diaz-Rubio E, Furio V, et al. Lethal cardiac toxicity after cisplatin and 5-fluorouracil chemotherapy: Report of a case with necropsy study. Am J Clin Oncol 1989; 12: 229-34.
18. Kuropkat C, Griem K, Clark J, et al. Severe cardiotoxicity during 5-fluorouracil chemotherapy: A case and literature report. Am J Clin Oncol 1999; 22: 466-70.
19. Tsibiribi P, Bui-Xuan C, Bui-Xuan B, et al. Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum Exp Toxicol 2006; 25: 305-9.
20. Lee L, Kukreti V. Rituximab-induced coronary vasopasm. Case Rep Hematol 2012; 2012: 984986 http: //www.hindawi.com/crim/hematology/2012/984986/
21. Basselin C, Fontanges T, Descotes J, et al. 5-Fluorouracil-induced Takotsubo-like syndrome. Pharmacotherapy 2011; 31: 226.